Global Pertussis Market, By Diagnosis (Blood Tests, Chest X-Ray, Nose or Throat Culture & Test, Others), Treatment (Medication, Vaccination, Supportive Treatments, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Pertussis Market Analysis and Size
The global pertussis market is expected to witness significant growth during the forecast period. Increased awareness programmes for pertussis vaccination, continuous rising demand to treat pertussis infection and procurement of vaccine by WHO, UNICEF and other government authorities in poor or developing countries will boost up the pertussis market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global pertussis market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Pertussis is a highly contagious respiratory disease causes by Bordetella pertussis, a bacteria that lives in nose, mouth and throat. It is also called as whooping cough. Infants & children are at major risk for the infection and spread easily from person to person through droplets produced by coughing or sneezing. Initial symptoms generally appear after 7-10 days of infection which includes rainy nose, mild fever & cough, other symptoms are pneumonia (common), pneumonia, encephalopathy (rare). Pertussis infection can be prevented by immunization/vaccination.
Pertussis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis (Blood Tests, Chest X-Ray, Nose or Throat Culture & Test, Others), Treatment (Medication, Vaccination, Supportive Treatments, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Merck KGaA (Germany), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), GSK plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), AstraZeneca (U.K.), Lilly (U.S.)
|
|
Market Opportunities
|
|
Global Pertussis Market Dynamics
Drivers
- Increased Cases of Whooping Cough
The rising prevalence of whooping cough led to the market growth expansion. As per the reports of the World Health Organization (WHO), in 2018, there were about 151,000 cases of pertussis all over the globe. Thus, it boosts the market growth.
Opportunities
- Increasing Air Pollution
As per the World Bank data records, around 95% of deaths are caused by air pollution that occur in low- and middle- income countries in the year 2019. Additionally, the trend of unhealthy lifestyle such as lack of physical exercise, smoking, and direct or indirect presence of chemicals are expected to boost the market growth in the future. This creates more opportunity to the market
- Increasing Demand for Retail Pharmacies
The rise in the number of perinatal infections therapeutics being delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create great opportunities for the market expansion. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of healthcare professionals who cannot treat the patients with appropriate treatments could curb the growth of the global pertussis market over a forecast period.
- High Cost
The huge expenditure associated with pertussis medications surely hamper the market growth.
This global pertussis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pertussis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Pertussis Market
Considering the present scenario, COVID-19 has left a major global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
Although during the pandemic, the attention was driven towards the COVID-19 patients majorly and hospitals and clinics were occupied with these patients but in the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge growth in the future, as research and treatments are drifting again towards the normal patients. Thus, this will leave a significant impact on the global pertussis market.
Global Pertussis Market Scope
The global pertussis market is segmented on the basis of diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Blood Tests
- Chest X-Ray
- Nose or Throat Culture & Test
- Others
Treatment
- Medication
- Vaccination
- Supportive Treatments
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Pertussis Market Regional Analysis/Insights
The global pertussis market is analysed and market size insights and trends are provided by diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global pertussis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global pertussis market throughout the forecasted period due to rising prevalence of neonatal neurological disorders
Asia-Pacific dominates the market due to increased WHO & government awareness programs and increased zika virus infection in Asian countries.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Pertussis Market Share Analysis
The global pertussis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pertussis market
Key players operating in the global pertussis market include:
- Merck KGaA (Germany)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- GSK plc (U.K.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- AstraZeneca (UK)
- Lilly (U.S.)
SKU-